Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : ABBV save search
AbbVie, Evolus, and Medytox Announce Resolution of Intellectual Property Litigation
Published: 2021-02-19 (Crawled : 17:00) - biospace.com/
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: 0.16%
H: 0.44%
C: -1.15%
EOLS | $12.05 1.35% 1.33% 500K
|
Health Technology
|
| O: 48.18%
H: 39.59%
C: 15.83%
AbbVie and Immunome Announce Strategic Collaboration to Discover Multiple Novel Oncology Targets
Published: 2023-01-06 (Crawled : 13:20) - prnewswire.com
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: 0.83%
H: 1.98%
C: 1.04%
IMNM | $18.36 -2.6% -2.67% 880K
|
Health Technology
|
| O: 21.66%
H: 4.71%
C: -17.63%
collaboration
CERE MERGER ANNOUNCEMENT: Julie & Holleman LLP Announces Investigation Into Potential Claims Regarding AbbVie's Proposed Acquisition of Cerevel Therapeutics
Published: 2023-12-07 (Crawled : 05:00) - prnewswire.com
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: 1.97%
H: 0.0%
C: 0.0%
CERE 4 | $41.34 -0.86% -0.87% 1.4M
|
Finance
|
| O: 12.02%
H: 0.92%
C: -0.58%
acquisition therapeutics potential
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
Published: 2023-12-06 (Crawled : 22:00) - prnewswire.com
MS 3 d | $89.14 2.47% 0.0% 18M
|
Finance
|
| O: 0.44%
H: 1.01%
C: 0.74%
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: 1.97%
H: 0.0%
C: 0.0%
IMGN | $31.23 0.03% 49M
|
Health Technology
|
| O: 0.31%
H: 0.38%
C: 0.38%
CERE 4 | $41.34 -0.86% -0.87% 1.4M
|
Finance
|
| O: 12.02%
H: 0.92%
C: -0.58%
abbvie pipeline acquire therapeutics
AbCellera and AbbVie Partner to Advance New Antibody Therapies
Published: 2022-12-15 (Crawled : 12:20) - biospace.com/
ABCL | $4.06 -2.87% -2.96% 1.3M
|
|
| O: 9.97%
H: 1.44%
C: -6.64%
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: -0.59%
H: 0.44%
C: -0.48%
antibody
Coherus and Junshi Biosciences to Host Virtual Investor Event to Discuss Toripalimab and ASCO 2021 Highlights– Virtual investor event to take place on Monday, June 7, 2021 at 6 p.m. ET –
Published: 2021-06-04 (Crawled : 23:00) - biospace.com/
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: 0.17%
H: 0.63%
C: -0.04%
CHRS | $2.155 -2.05% -2.09% 1.4M
|
Health Technology
|
| O: 7.36%
H: 1.43%
C: -5.21%
Infinity Pharmaceuticals Reports Full Year 2022 Financial Results
Published: 2023-03-28 (Crawled : 21:00) - biospace.com/
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: 0.17%
H: 0.51%
C: 0.29%
MEIP | $3.2 -1.54% -1.56% 16K
|
Health Technology
|
| O: 0.42%
H: 1.49%
C: -5.73%
INFI | $0.016 12.5% 1.1M
|
Health Technology
|
| O: 5.74%
H: 5.43%
C: -0.52%
year pharmaceuticals financial results
Kadcyla Leads the Global Antibody Drug Conjugates Market with Extensive Use in Breast Cancer Treatment
Published: 2023-11-01 (Crawled : 18:00) - prnewswire.com
ALPMY | $9.2715 -1.11% 500K
|
Manufacturing
|
| O: -1.46%
H: 3.67%
C: 3.26%
ZYME | $8.95 -1.54% -1.56% 260K
|
Health Technology
|
| O: 1.14%
H: 0.42%
C: -0.7%
TAK | $13.23 0.38% 0.0% 2.3M
|
Health Technology
|
| O: 1.03%
H: 0.73%
C: 0.58%
ADCT | $4.44 1.6% 0.0% 240K
|
Health Technology
|
| O: -0.16%
H: 6.42%
C: 4.49%
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: -0.86%
H: 0.0%
C: 0.0%
STRO M | $3.94 -4.83% -5.08% 770K
|
Health Technology
|
| O: 0.39%
H: 3.86%
C: 3.86%
IMGN | $31.23 0.03% 49M
|
Health Technology
|
| O: 5.09%
H: 5.48%
C: -1.27%
GILD | $67.32 -0.64% -0.64% 5M
|
Health Technology
|
| O: -0.47%
H: 1.88%
C: 1.78%
EXEL 4 | $22.83 0.57% 0.57% 1.7M
|
Health Technology
|
| O: -2.62%
H: 1.17%
C: -1.66%
drug antibody breast cancer treatment global market
Breast Cancer Therapeutics Market 2023, USD 15.64 billion Growth is Expected between 2023 to 2028, Robust pipeline and new drug approvals to Boost Growth - Technavio
Published: 2024-01-30 (Crawled : 18:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 5.68%
H: 0.77%
C: 0.77%
AZNCF | $135.94 -4.19% 770
|
Health Technology
|
| O: 3.41%
H: 0.0%
C: -2.45%
VTRS | $11.12 -1.77% -1.8% 6.8M
|
Health Technology
|
| O: -0.08%
H: 3.47%
C: -0.25%
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
|
| O: -2.04%
H: 0.19%
C: -1.97%
GSK | $39.95 -1.36% 0.0% 2.4M
|
Health Technology
|
| O: 4.04%
H: 1.57%
C: -3.02%
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: 0.5%
H: 0.07%
C: -0.81%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 1.75%
H: 0.0%
C: 0.0%
PBYI | $5.1 -4.67% -4.9% 290K
|
Health Technology
|
| O: -0.1%
H: 2.31%
C: -1.26%
AZN | $68.27 -0.67% -0.67% 3.8M
|
Health Technology
|
| O: 0.82%
H: 0.12%
C: -1.64%
AMGN | $265.64 0.05% 0.05% 2M
|
Health Technology
|
| O: 0.44%
H: 0.2%
C: -0.55%
drug breast expected cancer pipeline therapeutics growth market
Topical Corticosteroids Market to Grow by USD 1.08 billion between 2022 to 2027, globally at 4% CAGR - Technavio
Published: 2024-01-30 (Crawled : 23:00) - prnewswire.com
ALPMF | $9.48 43.47% 1.7K
|
Health Technology
|
| O: 4.34%
H: 0.0%
C: 0.0%
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 5.68%
H: 0.77%
C: 0.77%
AZNCF | $135.94 -4.19% 770
|
Health Technology
|
| O: 3.41%
H: 0.0%
C: -2.45%
ALPMY | $9.2715 -1.11% 500K
|
Manufacturing
|
| O: 0.0%
H: 1.38%
C: 0.26%
VTRS | $11.12 -1.77% -1.8% 6.8M
|
Health Technology
|
| O: -0.08%
H: 3.47%
C: -0.25%
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
|
| O: -2.04%
H: 0.19%
C: -1.97%
GSK | $39.95 -1.36% 0.0% 2.4M
|
Health Technology
|
| O: 4.04%
H: 1.57%
C: -3.02%
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: 0.5%
H: 0.07%
C: -0.81%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 1.75%
H: 0.0%
C: 0.0%
AZN | $68.27 -0.67% -0.67% 3.8M
|
Health Technology
|
| O: 0.82%
H: 0.12%
C: -1.64%
market
Global Microarray Market Report 2022: Large-Scale DNA/Gene Chip Initiatives to Drive Sector Moving Forward
Published: 2022-11-09 (Crawled : 21:00) - prnewswire.com
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
|
| O: 2.81%
H: 0.43%
C: -0.2%
MDT | $79.25 -1.22% 0.0% 7.1M
|
Health Technology
|
| O: 3.56%
H: 0.11%
C: -0.33%
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: 2.06%
H: 0.0%
C: -0.62%
ABT | $109.21 0.29% 0.34% 7.3M
|
Health Technology
|
| O: 3.59%
H: 1.37%
C: 1.16%
global report chip market
Global Hairy Cell Leukemia Market Analysis & Forecast 2024-2034
Published: 2024-02-02 (Crawled : 03:00) - prnewswire.com
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
|
| O: -0.5%
H: 0.26%
C: -1.03%
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: -0.15%
H: 0.0%
C: 0.0%
BMY | $48.26 -0.52% 0.04% 12M
|
Health Technology
|
| O: 1.23%
H: 1.5%
C: -1.14%
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: 3.59%
H: 0.0%
C: 0.0%
AMGN | $265.64 0.05% 0.05% 2M
|
Health Technology
|
| O: -0.28%
H: 0.66%
C: -0.14%
cell global leukemia market
Heart Transplantation Therapeutics Market Projected for USD 135.37 Million Growth between 2024 and 2028: Market to Focus on Newer Techniques for Heart Transplantation - Technavio
Published: 2024-02-02 (Crawled : 09:00) - prnewswire.com
ALPMF | $9.48 43.47% 1.7K
|
Health Technology
|
| O: -3.89%
H: 0.0%
C: 0.0%
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -0.7%
H: 0.0%
C: 0.0%
ALPMY | $9.2715 -1.11% 500K
|
Manufacturing
|
| O: -4.76%
H: 7.0%
C: 3.18%
GSK | $39.95 -1.36% 0.0% 2.4M
|
Health Technology
|
| O: -0.05%
H: 0.59%
C: 0.27%
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: 3.59%
H: 0.0%
C: 0.0%
million heart therapeutics growth market
AbbVie Reports Full-Year and Fourth-Quarter 2023 Financial Results
Published: 2024-02-02 (Crawled : 14:00) - biospace.com/
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: 3.59%
H: 0.0%
C: 0.0%
abbvie financial results
Pfizer Reports First-Quarter 2022 Results
Published: 2022-05-03 (Crawled : 12:00) - biospace.com/
PFE A | $25.69 -0.85% 0.1% 29M
|
Health Technology
|
| O: 1.77%
H: 2.39%
C: 0.86%
BHVN | $43.77 -2.23% 0.0% 1.9M
|
Health Technology
|
| O: 4.37%
H: 0.98%
C: -3.34%
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
SGMO | $0.5422 -2.32% -2.38% 990K
|
Health Technology
|
| O: 7.97%
H: 2.91%
C: 0.0%
OPK | $1.22 -0.81% -0.82% 4M
|
Health Technology
|
| O: 2.94%
H: 4.64%
C: 3.21%
BNTX | $86.3 -1.81% -1.84% 780K
|
Health Technology
|
| O: 3.06%
H: 3.6%
C: 2.08%
BEAM | $25.7 0.0% 1.4M
|
Health Technology
|
| O: 8.78%
H: 3.69%
C: -2.08%
results
Retinal drugs market size to increase by USD 7.27579 billion; North America to account for 42% of market growth - Technavio
Published: 2023-02-08 (Crawled : 12:20) - prnewswire.com
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
|
| O: 0.72%
H: 0.52%
C: -0.08%
ALC | $79.61 -1.83% 0.0% 1.1M
|
Health Technology
|
| O: 0.28%
H: 0.21%
C: -0.41%
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: 0.19%
H: 0.65%
C: -0.55%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 3.05%
H: 0.0%
C: 0.0%
MGTX 4 | $5.42 -0.91% -0.92% 130K
|
Health Technology
|
| O: -1.14%
H: 4.62%
C: -0.77%
america growth market
Ironwood Pharmaceuticals Reports Third Quarter 2023 Results
Published: 2023-11-09 (Crawled : 13:30) - biospace.com/
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: -1.81%
H: 0.43%
C: -2.1%
IRWD | $7.88 1.16% 1.14% 2.1M
|
Health Technology
|
| O: 2.93%
H: 4.37%
C: 0.21%
pharmaceuticals ironwood results
The Medical Aesthetics Market to grow at a CAGR of 8.6% from 2022 to 2027; Increasing global awareness about medical aesthetics to boost market growth - Technavio
Published: 2023-08-14 (Crawled : 09:00) - prnewswire.com
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: 0.62%
H: 0.08%
C: -0.49%
XRAY | $30.805 -0.27% -0.28% 3M
|
Health Technology
|
| O: -0.18%
H: 0.08%
C: -1.21%
ANIK | $25.6 1.15% 1.13% 52K
|
Health Technology
|
| O: 2.89%
H: 2.53%
C: -0.98%
global medical growth market
NEXGEL Secures Supply Agreement with AbbVie
Published: 2023-10-30 (Crawled : 12:00) - globenewswire.com
NXGL | $2.15 -1.38% -1.4% 33K
|
Manufacturing
|
| O: 5.0%
H: 12.49%
C: -4.76%
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: 2.87%
H: 0.0%
C: 0.0%
abbvie agreement
AbbVie Seeks New Indication for Migraine Drug Qulipta, Drops Deal with Morphic
Published: 2022-06-22 (Crawled : 16:00) - biospace.com/
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: 2.73%
H: 4.44%
C: 2.67%
drug deal migraine
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
WISA 4 | $6.06 246.29% 71.12% 200M
|
Electronic Technology
VIAO | $0.265 -13.96% 35.85% 960K
|
Electronic Technology
JAGX | $0.178 49.83% 33.26% 600M
|
Health Technology
SXTC | $1.68 43.59% 30.36% 34M
|
Health Technology
DYNT | $0.531 43.36% 30.24% 22M
|
Health Technology
KA | $0.4796 41.06% 29.11% 5.3M
|
Manufacturing
PALI | $5.86 40.87% 29.01% 29M
|
Manufacturing
CLNN | $0.319 -3.74% 28.75% 6.3M
|
BSGM | $1.52 38.18% 27.63% 3.3M
|
Health Technology
MCBC | $13.67 37.66% 27.36% 2.2M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.